GTSE1, CDC20, PCNA, and MCM6 Synergistically Affect Regulations in Cell Cycle and Indicate Poor Prognosis in Liver Cancer

Table 1

GTSE1 expression and clinical factors.

Clinical factor	Cases	GTSE1 median	GTSE1 expression		value
			Low	High
Age (years)
<40	29	6.251	14	15	0.846
≥40	311		156	155
Ethnicity
Hispanic or Latino	17	6.492	7	10	0.461
Not Hispanic or Latino	310		156	154
Race
White	169	6.463	97	72	0.010
Black or African American	15		9	6
Asian	148		59	89
American Indian or Alaska Native	1		1	0
Tumor purity
<0.6	28	6.455	11	17	0.242
≥0.6	315		160	155
Residual tumor
r0	303	6.397	151	152	0.586
r1	15		7	8
r2	1		1	0
Pathologic stage
Stage i	161	6.463	92	69	0.010
Stage ii	77		34	43
Stage iii	80		31	49
Stage iv	3		3	0
Pathology T stage
t1	168	6.465	97	71	0.027
t2	84		37	47
t3	75		29	46
t4	13		7	6
Pathology N stage
n0	239	6.593	120	119	0.561
n1	3		1	2
Pathology M stage
m0	245	6.514	121	124	0.081
m1	3		3	0

Cases from TCGA-LIHC were divided into the GTSE1 low and high groups by the median value of normalized GTSE1 expression signal as the cutoff value. values with significance were shown in bold.